The combination of IL-2 nanoparticles and Palbociclib enhances the anti-tumor immune response for colon cancer therapy

ABSTRACT:

SUBMITTER: Wang D 

PROVIDER: S-EPMC10861758 | biostudies-literature | 2024 Jan

REPOSITORIES: biostudies-literature